Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
EurekAlert!2d
Duke-NUS study targets proteins to reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists ...
pulmonaryfibrosisnews3h
Runx2 protein may be treatment target for pulmonary fibrosis
A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows.
Lung Diseases You Are Prone To If Exposed To Air Pollution
Long-term exposure to toxic air pollutants, particularly carcinogens like benzene, formaldehyde, and polycyclic aromatic ...
pulmonaryfibrosisnews7d
Nerandomilast shows promise for progressive pulmonary fibrosis
Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...
Yahoo Finance11d
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
Pliant Therapeutics announced it has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of ...
Scientists Discover How Newborn Immune Cells Repair the Heart While Adults Scar
Researchers found that newborn immune cells regenerate heart tissue by producing thromboxane. Mimicking this process in ...
pharmaphorum11d
Pliant slumps on decision to pause lung disease drug trial
The drug is a dual-selective inhibitor of αvβ6 and αvβ1 integrins, which are seen in elevated levels in the lung tissue of IPF patients and are thought to promote fibrosis (scarring ...